Redesignates existing section 36 as section 37 and inserts a new section 36 into the National Institute of Standards and Technology Act establishing a National Biopharmaceutical Center of Excellence with authorities, objectives, funding, application and selection processes, reporting requirements, intellectual property guidelines, an authorization of appropriations, and definitions.